𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic factors in thin cutaneous malignant melanoma

✍ Scribed by Eva Månsson-Brahme; John Carstensen; Kerstin Erhardt; Bengt Lagerlöf; Ulrik Ringborg; Lars Erik Rutqvist


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
805 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background. Thin melanomas can metastasize and be lethal. The predictive importance of tumor thickness in thin melanomas and the specific features identifying the patients at risk have not been investigated fully.

Methods. Prognostic factors were analyzed in 585 patients with clinical Stage I invasive cutaneous malignant melanoma with a thickness of less than or equal to 0.8 mm. The patients were included in a population-based cancer registry in Stockholm county during 1976-1987. They constituted about 64% of all patients with thin melanomas who were diagnosed in the region during the study period. Information was available on age, sex, anatomic site of the tumor, histologic type of melanoma, level of invasion, tumor thickness, and tumor regression. In a Cox regression analysis, the prognostic importance of each factor was studied. By a case-control technique with individual matching for the identified independent predictors of recurrence, the additional prognostic information given by type and grade of inflammatory response, presence of vertical growth phase, mitotic rate/mm2, and histologic ulceration of the tumor was assessed.

Results. After a median follow-up time of 50 months, recurrent disease developed in 26 patients (4%). There was no difference in recurrence rate between patients treated with narrow (1-2 cm) or wide (5 cm) excision. Anatomic site, tumor thickness, level of invasion, and tumor regression were found to be independent prognostic factors in the multivariate analysis. In the case-control study, only grade of inflammatory reaction added significant prognostic information. No subgroup could be identified that was without risk of recurrent disease.

Conclusions. Thin melanomas do not seem to constitute a separate form of melanoma, but compose one end From the


📜 SIMILAR VOLUMES


Prognostic factors for cutaneous maligna
✍ Fabio Levi; Lalao Randimbison; Carlo La Vecchia; Van-Cong Te; Silvia Franceschi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 72 KB 👁 2 views

We considered, by means of a multivariate approach, trends in survival from cutaneous malignant melanoma in relation to patient and tumor characteristics, using data from the Cancer Registry of the Swiss Canton of Vaud. Between 1980 and 1994, 1,229 cases of incident cutaneous malignant melanoma were

Molecular prognostic markers in intermed
✍ Tina J. Hieken; Salve G. Ronan; Miguel Farolan; Anne L. Shilkaitis; Tapas K. Das 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

## Background: The limitations of morphologic criteria alone in determining the prognosis for a patient with a particular intermediate-thickness primary melanoma have prompted efforts to identify other markers. ## Methods: In this study, the authors analyzed expression of p53, beta1 integrin, and

Prognostic factors in patients with thic
✍ Elizabeth Zettersten; Richard W. Sagebiel; James R. Miller III; Sreedhar Tallapu 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

## Abstract ## BACKGROUND The current study was conducted to examine the role of multiple clinical and histologic factors in the prognostic assessment of patients with thick primary melanoma (> 4 mm, classified as T4). ## METHODS A retrospective analysis was performed in 329 patients with T4 cut

Thin cutaneous malignant melanomas (≤1.5
✍ Daniela Massi; Alessandro Franchi; Lorenzo Borgognoni; Umberto Maria Reali; Marc 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Background: Although thin cutaneous melanomas generally have a favorable prognosis, in some cases they may undergo progression. the current study was undertaken to identify variables that may predict a more aggressive clinical outcome in these patients. in addition to classic clinicopathologic f